glp-1 and neuroinflammation Beyond diabetes obesity: GLP‐1 receptor agonists in disrupting the vicious cycle of metabolic dysfunction and - Spezani - 2026 - Diabetes, Obesity and Metabolism Frontiers | GLP-1 receptor agonist

However, in March 2025, Federal Health Minister Mark Butler wrote to the PBAC to seek their expert advice on equitable access to obesity medicines through the PBS, recognising the potential benefits but also the significant cost to the healthcare system of subsidising these medicines, the spokesperson told newsGP

But as I spoke with him, I noticed something that did not fit: beads of sweat were running down his forehead

Confirm the exact mechanics with the brand before ordering, since this article couldn't verify them against a dedicated policy page

In the placebo groups, 20 patients developed UTIs

Frequently asked questions Does tirzepatide directly cause hair loss